Recombinant Dna Technology Market Set To Witness Significant Growth By 2024-2031: Sanofi , Pfizer, Inc., Amgen, Inc. Recombinant Dna technology market is expected to reach USD 327.63 Bn by 2031, ...
Patient advocacy group uses report data to push solutions on air pollution, access to medicine, health equity 2024 Asthma ...
Medpage Today on MSN21h
Acne Treatments Taken Right Off the Shelf Had High Levels of BenzeneDozens of over-the-counter acne products had very high levels of the known carcinogen benzene, even when they were taken ...
Innovent partners with over 30 global healthcare companies, including Eli Lilly, Sanofi, Incyte, Adimab ... a global clinical trial collaboration and supply agreement with Amgen Inc. Amgen will lead a ...
China-headquartered clinical-stage biotech MediLink Therapeutics has announced a global clinical trial collaboration and ...
Israel-based Teva Pharmaceutical Industries today announced that the US Food and Drug Administration (FDA) has accepted, and ...
Potential new benefit for home health care for seniors to be funded through Medicare drug price negotiations, likely ...
Sanofi India Limited (Previously known as Aventis Pharma Limited) was incorporated in May 1956. The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11 2012. The ...
The objectives of this symposium were to improve attendees’ knowledge on ADT, including the different therapeutic options ...
Global immunotherapy drugs market is valued at approximately USD 247.44 billion in 2023 and is projected to grow at a healthy CAGR of 15.3% over the forecast period 2024-2032. Request To Download Free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback